ATARA BIOTHERAPEUTICS, INC. (ATRA) Free cash flow 2016–2025
ATARA BIOTHERAPEUTICS, INC. (ATRA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$50.9MFY2025 · since FY2016: -$63.0M → -$50.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$50.9M | +26.1% |
| FY2024 | -$69.0M | +64.5% |
| FY2023 | -$194.2M | +29.3% |
| FY2022 | -$274.6M | -18.8% |
| FY2021 | -$231.1M | -24.7% |
| FY2020 | -$185.3M | +23.2% |
| FY2019 | -$241.4M | -11.9% |
| FY2018 | -$215.7M | -100.2% |
| FY2017 | -$107.7M | -70.9% |
| FY2016 | -$63.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ATRA financial trends
ATRA RevenueATRA Net incomeATRA Net marginATRA Gross profitATRA Gross marginATRA Operating incomeATRA Operating marginATRA Operating cash flowATRA Capital expendituresATRA Return on equityATRA Stock buybacksATRA Dividends paidATRA Total assetsATRA Total liabilitiesATRA Shareholders’ equityATRA overview →